Haleon plc
https://www.haleon.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Haleon plc
Finance Watch: Pfizer Adds $3.5bn To Cash Stockpile, Reduces Stake In Haleon
Public Company Edition: Pfizer’s stake in Haleon dropped from 32% to 22.6% with a massive sale of shares of the GSK consumer health spinout. Also, Galderma prices its Swiss IPO, Madrigal grosses $600m in a post-approval offering and bluebird secured up to $175m in debt.
Demi Moore’s Wonderbelly Antacids Investment Lands Supporting Role In Her Promotional Posts
Wonderbelly Antacids “free from” ad claims work but failing to disclose Demi Moore is an investor in her promotions doesn’t, NAD says. Dakota Nutrition fails again on NAD’s test of its testing for elderberry in its supplements.
Nicorette Gum Package Front In US Adds Initial, Zyrtec Labeling Gets ‘New’ For Limited Time
Front panels for 34 SKUs for Haleon’s Nicorette 2- and 4-mg gum in approved to include a superimposed letter N; labeling approved for seven SKUs for Kenvue’s Zyrtec Allergy 5- and 10-mg tablets to include “new” for six months.
Futura Extends Europe Licensing Agreement With Cooper For Eroxon ED Gel
Futura Medical has extended its licensing agreement with Cooper Consumer Health for the rights to market its Eroxon topical, gel-based erectile dysfunction treatment throughout the European Economic Area, United Kingdom and Switzerland until 2029.
Company Information
- Industry
-
Pharmaceuticals
- OTC, Consumer
- Other Names / Subsidiaries
-
- GSK/Pfizer JV
- Hindustan Milkfood Manufacturers Pvt Ltd
- HMM Ltd.
- SmithKline Beecham Brands Ltd.
- SmithKline Beecham Consumer Healthcare Ltd.
- GlaxoSmithKline Consumer Healthcare Limited
- GSK Consumer Healthcare
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice